Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High density lipoprotein and coronary heart disease.

Literature DB >> 2499385

High density lipoprotein and coronary heart disease.

D J Betteridge¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1989 PMID： 2499385 PMCID： PMC1836317 DOI： 10.1136/bmj.298.6679.974

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

11 in total

1. The interaction of high-density lipoproteins with extrahepatic cells.

Authors: E L Bierman; J F Oram
Journal: Am Heart J Date: 1987-02 Impact factor: 4.749

2. Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.

Authors: J M Ordovas; E J Schaefer; D Salem; R H Ward; C J Glueck; C Vergani; P W Wilson; S K Karathanasis
Journal: N Engl J Med Date: 1986-03-13 Impact factor: 91.245

3. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors: W T Friedewald; R I Levy; D S Fredrickson
Journal: Clin Chem Date: 1972-06 Impact factor: 8.327

Review 4. High-density lipoprotein: a major risk factor for coronary atherosclerosis.

Authors: N E Miller
Journal: Baillieres Clin Endocrinol Metab Date: 1987-08

5. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors: G J Miller; N E Miller
Journal: Lancet Date: 1975-01-04 Impact factor: 79.321

6. The triglyceride issue: a view from Framingham.

Authors: W P Castelli
Journal: Am Heart J Date: 1986-08 Impact factor: 4.749

7. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Authors: V Manninen; M O Elo; M H Frick; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen
Journal: JAMA Date: 1988-08-05 Impact factor: 56.272

8. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors: D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal: JAMA Date: 1987-06-19 Impact factor: 56.272

High density lipoprotein and coronary heart disease.

1. The interaction of high-density lipoproteins with extrahepatic cells.

2. Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.

3. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Review 4. High-density lipoprotein: a major risk factor for coronary atherosclerosis.

5. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

6. The triglyceride issue: a view from Framingham.

7. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

8. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

9. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

10. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man.

1. Brisk walking and high density lipoprotein cholesterol.

2. HDL as an independent risk factor in British men (and women)